Table 2.
Animal ID | Day of Death | CD45 Immunoreactive | Interpretation | ||
---|---|---|---|---|---|
Group 1 | |||||
Control males, scheduled deaths | 101 | 4 | no significant microscopic lesions | ||
103 | 4 | ||||
105 | 4 | ||||
108 | 31 | ||||
110 | 31 | ||||
112 | 31 | ||||
113 | 61 | ||||
116 | 61 | ||||
117 | 61 | ||||
Control females, scheduled deaths | 151 | 4 | no significant microscopic lesions | ||
153 | 4 | ||||
155 | 4 | ||||
157 | 31 | ||||
160 | 31 | ||||
162 | 31 | ||||
163 | 61 | ||||
165 | 61 | ||||
167 | 61 | ||||
Group 2 | |||||
CPA males, scheduled deaths | 202 | 4 | no significant microscopic lesions | ||
204 | 4 | ||||
206 | 4 | ||||
208 | 31 | ||||
210 | 31 | ||||
211 | 31 | ||||
214 | 61 | ||||
CPA males, early deaths | 215 | 52 (FD) | cause of death not apparent | ||
218 | 55 (FD) | cause of death not apparent | |||
CPA females, scheduled deaths | 252 | 4 | no significant microscopic lesions | ||
254 | 4 | ||||
256 | 4 | ||||
257 | 31 | ||||
259 | 31 | ||||
262 | 31 | ||||
267 | 61 | ||||
CPA females, early deaths | 264 | 59 (FD) | cause of death not apparent | ||
265 | 54 (FD) | cause of death not apparent | |||
Group 3 | |||||
4.2 × 104 PFU virus, male scheduled deaths | 302 | 4 | minimal HSV infection of nervous tissue in the absence of cytopathic effect or inflammatory change | ||
304 | 4 | no significant microscopic lesions | |||
306 | 4 | √ | minimal HSV infection of nervous tissue in the absence of cytopathic effect or inflammatory change | ||
307 | 31 | no significant microscopic lesions | |||
312 | 31 | no significant microscopic lesions | |||
315 | 31 | no significant microscopic lesions | |||
314 | 61 | no significant microscopic lesions | |||
317 | 61 | no significant microscopic lesions | |||
4.2 × 104 PFU virus, female scheduled deaths | 352 | 4 | no significant microscopic lesions | ||
354 | 4 | √ | minimal viral infection with no cytopathic effect and a minimal inflammatory response | ||
356 | 4 | √ | minimal viral infection of ependyma and periventricular tissues in the absence of cytopathic effect and a minimal inflammatory response | ||
358 | 31 | no significant microscopic lesions | |||
359 | 31 | no significant microscopic lesions | |||
361 | 31 | no significant microscopic lesions | |||
367 | 61 | no significant microscopic lesions | |||
4.2 × 104 PFU virus, male early deaths | 309 | 6 (FD) | cause of death not apparent | ||
316 | 53 (FD) | cause of death not apparent | |||
4.2 × 104 PFU virus, female early deaths | 365 | 54 (FD) | cause of death not apparent | ||
364 | 55 (FD) | √ | death attributed to viral infection in brain | ||
Group 4 | |||||
3 × 103 PFU virus + CPA, male scheduled deaths | 402 | 4 | no significant microscopic lesions | ||
404 | 4 | no significant microscopic lesions | |||
406 | 4 | there was a single HSV antigen-positive cell that was not associated with cytopathic effect or an inflammatory response | |||
408 | 31 | no significant microscopic lesions | |||
410 | 31 | no significant microscopic lesions | |||
411 | 31 | no significant microscopic lesions | |||
415 | 61 | no significant microscopic lesions | |||
3 × 103 PFU virus + CPA, female scheduled deaths | 452 | 4 | no significant microscopic lesions | ||
454 | 4 | no significant microscopic lesions | |||
456 | 4 | no significant microscopic lesions | |||
458 | 31 | minimal focal viral infection in the absence of inflammatory responses or cytopathic effect | |||
459 | 31 | no significant microscopic lesions | |||
461 | 31 | no significant microscopic lesions | |||
464 | 61 | no significant microscopic lesions | |||
466 | 61 | no significant microscopic lesions | |||
3 × 103 PFU virus + CPA, male early deaths | 418 | 53 (FD) | cause of death not apparent | ||
413 | 54 (FD) | cause of death not apparent | |||
3 × 103 PFU virus + CPA, female early death | 467 | 53 (FD) | cause of death not apparent |
FD, found dead.